Every day, Global University Venturing rounds up the smaller investments from across the university innovation ecosystem in its deal net.
Elypta, a Sweden-based molecular diagnostics spinout of Chalmers University of Technology, has closed a €6.1m ($6.7m) seed round featuring the university’s investment and incubator arm Chalmers Ventures. State-owned investment unit Industrifonden and equity crowdfunding platform Sciety co-led the round with participation from social entrepreneurship incubator Norrsken Foundation and seed fund Nina Capital. The cash will go to progressing laboratory kits and software for Elypta’s cancer liquid biopsy platform, which exploits biomarkers in metabolism. Chalmers Ventures became an anchor shareholder when Elypta was formed in 2017 to drive research by Jens Nielsen, professor of quantitative systems biology, and Francesco Gatto, a visiting researcher at the university.
Eolo Pharma, a Uruguay-based spinout of Portal Universidad de la República and Institut Pasteur of Montevideo, has received $2.7m of series A funding for preclinical studies on a potential treatment for obesity. Cites, a venture fund and accelerator owned by insurance group Sancor Seguros…
